Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 6:57 PM
Study NCT ID:
NCT01235260
Status:
COMPLETED
Last Update Posted:
2016-07-19
First Post:
2010-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-04
First Submit QC Date:
None
Study First Post Date:
2010-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-15
Last Update Post Date:
2016-07-19
Last Update Post Date Type:
ESTIMATED